Unaudited Standalone Financial Results of the company for the Quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mardia Samyoung Capillary Tubes Company Ltd reported weak Q1 FY26 (quarter ended June 30, 2025) results with total income of just ₹11.75 lakhs, compared to ₹276.32 lakhs for the full FY25. The company posted a net loss of ₹22.88 lakhs in Q1 FY26, a sharp deterioration from the net profit of ₹119.95 lakhs reported for FY25, and also wider than the ₹5.39 lakh loss in the corresponding Q1 FY25. Total expenses stood at ₹22.88 lakhs, dominated by other expenses of ₹21.55 lakhs and employee benefit costs of ₹1.36 lakhs, with no material costs or finance/depreciation charges. No exceptional items were booked. The statutory auditors, Agrawal & Agrawal Associates, issued an unmodified limited review report on the results.
The company has swung back into losses in Q1 FY26 with very thin revenue, signalling weak operational momentum and continued cash burn for shareholders. The stock is likely to remain under pressure given the sharp reversal from FY25 profitability.